SLPI Antibodies

Target Information

Acid-stable proteinase inhibitor with strong affinities for trypsin, chymotrypsin, elastase, and cathepsin G. Modulates the inflammatory and immune responses after bacterial infection, and after infection by the intracellular parasite L.major. Down-regulates responses to bacterial lipopolysaccharide (LPS). Plays a role in regulating the activation of NF-kappa-B and inflammatory responses. Has antimicrobial activity against mycobacteria, but not against salmonella. Contributes to normal resistance against infection by M.tuberculosis. Required for normal resistance to infection by L.major. Required for normal wound healing, probably by preventing tissue damage by limiting protease activity. Together with ELANE, required for normal differentiation and proliferation of bone marrow myeloid cells. Detected in blood plasma (PubMed:24352879). Detected in bone marrow myeloid cells (PubMed:24352879). Detected in airway sputum (PubMed:2039600). Detected in parotid gland secretions (PubMed:3462719). Detected in seminal plasma (at protein level) (PubMed:3485543). Detected in uterus cervix (PubMed:3533531). Note: This description may include information from UniProtKB.

Alternate Names

ALK1; ALP; Antileukoproteinase; BLPI; HUSI; HUSI-1; HUSI-I; MPI; mucus proteinase inhibitor; OTTHUMP00000031775; P03973; Protease inhibitor WAP4; secretory leukocyte peptidase inhibitor; Secretory leukocyte protease inhibitor; secretory leukocyte protease inhibitor; secretory leukocyte protease inhibitor (antileukoproteinase); seminal proteinase inhibitor; SLPI; Slpi; WAP four-disulfide core domain 4; WAP four-disulfide core domain protein 4; WAP4; WFDC4